Chitosan, poly(vinyl alcohol) and bovine bone powder biocomposites were designed.
The biocomposites have reliable physicochemical properties to be used as biomaterials.
The biocomposites were assessed to treat DNCB-induced skin lesions in an AD-like model.
In vivo assays show that the biocomposites can attenuate and treat AD skin lesions.